Skip to main content
. 2002 Nov 22;546(Pt 1):191–205. doi: 10.1113/jphysiol.2002.027607

Table 3.

Effects of Ni2+, Co2+ and aminoglycosides on the properties of pacemaker potentials

Membrane potential (mV) Amplitude (primary, mV) Amplitude (primary, mV) Frequency (min−1) Half-width (s) dV/dtmax(V s−1) n
Control −63.2 ± 4.1 47.7 ± 5.0 49.6 ± 4.1 3.2 ± 0.5 9.0 ± 0.7 0.58 ± 0.17 5
Ni2+ 10 μm −62.3 ± 3.6 47.1 ± 4.6 8.3 ± 0.7** 3.5 ± 0.1** 0.50 ± 0.13 5
Control −63.0 ± 3.1 47.4 ± 2.6 49.5 ± 2.2 3.3 ± 0.8 7.7 ± 2.2 0.63 ± 0.16 5
Co2+ 10 μm −61.7 ± 4.5 46.1 ± 4.2 8.4 ± 1.3** 2.8 ± 0.4** 0.56 ± 0.14 5
Control −64.1 ± 2.0 47.1 ± 4.5 48.6 ± 4.6 3.3 ± 0.7 8.4 ± 0.8 0.48 ± 0.02 5
Neomycin 3 μm −63.1 ± 2.4 46.6 ± 4.7 48.6 ± 5.2 5.8 ± 0.6** 3.5 ± 1.0** 0.50 ± 0.08 5
Control −64.3 ± 3.1 47.2 ± 3.6 48.8 ± 2.8 3.3 ± 0.5 8.2 ± 1.2 0.53 ± 0.08 4
Gentamicin 3 μm −64.4 ± 2.6 47.4 ± 3.9 48.6 ± 3.6 6.2 ± 0.7** 3.9 ± 0.4* 0.50 ± 0.09 4

Values are means ± s.d.n = number of tissues.

*

P < 0.05

**

P < 0.01.